Our Mission is to stop cancer before it starts and to help you and your loved ones avoid cancer.
Our Philosophy is to provide a simple, convenient, accurate, economic, and effective tool to make cancer prevention and interception transparent, actionable, and measurable.
Our Foundation is the Art of War.
Our Silver Bullet is the iCRM, intelligent Cancer Risk Monitor, equipped with 13 unique cancer risk predictive algorithms and AI simulation techniques.
Will is a Professor of Oncology of Bengbu Medical University. Prior to AIH, Will was SVP of Wanbei Hospital. Will’s research focuses on surgical treatment of breast cancer and early detection of breast cancer. He is a member of the National Cancer Society and a committee member of the Anhui Province Cancer Society since 2002. Will received numerous awards in the last 20 years in recognition of his research contributions in the field of surgical treatment of breast cancer.
Co-founder & CTO
Prior to AIH, Qiu Ping was a Lead Data Engineer & Scientist of the Business Intelligence Group at IBM for about twelve years. He developed and delivered a wide variety of analytics projects with AI algorithms for banks and insurance companies. Qiu Ping received a Master’s Degree in Computer Science and a Master’s Degree in Biomechanics from Indiana University.
CO-FOUNDER & CAO
Prior to AIH, Liwei was Senior Vice President of Intelligent Platform Group at Yingli Tech. Liwei has been leading data science and analytics teams in various companies that include Apple, Yahoo, Chase & Expedia. Liwei is co-author of several cancer, AMI & stroke research studies. Liwei holds a MBA from Texas Christian University and a Ph. D in Kinesiology from Indiana University.
HEAD OF DATA SCIENCE & DIGITAL STRATEGY
Charles is responsible for designing ML predictive models and AI risk monitoring systems. Charles is co-inventor of three pending patents with machine learning algorithms helping people avoid cancer, AMI & stroke. Charles holds M.Sc. in Digital Information Technology from ETH Zurich (Swiss Federal Institute of Technology) and BS in Applied and Computational Mathematical Sciences from University of Washington Seattle.
Medical Research Advisor
Young is a Professor of Medicine at Anhui Medical University. Prior to AIH, Young was the Chief of the Division of Oncology of Fuyang City Hospital. His research has focused on thoracic surgery and he has been a member of the National Association for Thoracic Surgery since 1989. He received the National Award in 2004 in recognition of his research contributions in the field of surgical treatment of lung cancer.
Head of OPERATIONs
Prior to AIH, Shelly was Head of Operations at Yingli Tech. Shelly holds a Bachelor’s Degree in Business from Beijing Union University and a Master’s Degree in Psychology from Texas Christian University.
Young Young holds a BA in Finance and Economics from Western Washington University. He has been responsible for providing financial reports and marketing campaign ROI analysis.